Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics and board member of Europabio Thomas has been a board member of Europabio since June 2022 and chairs a variety of industry federation working groups. In the past he held other board positions at several European associations, such as Europabio and EUCOPE, and has represented industry on a variety of multistakeholder platforms, organized by the European Commission and the EU Council of Ministers. He is currently the co-chair of the WHO Access to Novel Medicines Platform Working group on Sustainability.